Showa University Fujigaoka Hospital
Yokohama, Kanagawa, Japan
University hospital in Yokohama
1 Chome-30 Fujigaoka, Aoba Ward, Yokohama, Kanagawa 227-8501
About Showa University Fujigaoka Hospital
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Bayer
3
Boehringer Ingelheim
3
Abbott Medical Devices
2
Japan Clinical Cancer Research Organization
2
Japan Rhabdomyosarcoma Study Group
2
Amgen
1
Associations for Establishment of Evidence in Interventions
1
JIMRO Co., Ltd.
1
North East Japan Study Group
1
Pfizer
1
Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan
1
Clinical Trials at Showa University Fujigaoka Hospital
During the past decade, Showa University Fujigaoka Hospital conducted 10 clinical trials. In the 10-year time frame, 10 clinical trials started and 3 clinical trials were completed, i.e. on
average, 30% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Vincristine, Dactinomycin, and Cyclophosphamide in Treating Patients With Embryonal Rhabdomyosarcoma
2004-05-01
Unknown status
41
Vincristine, Dactinomycin, and Cyclophosphamide With or Without Radiation Therapy in Treating Patients With Embryonal Rhabdomyosarcoma
2004-05-01
Unknown status
32
Phase III Study of Docetaxel + S-1 vs. S-1 for Advanced Gastric Cancer
2006-03-01
2010-10-01
Completed
628
Tegafur-Uracil or Observation in Treating Patients With Stage II Colorectal Cancer That Has Been Completely Removed By Surgery
2006-10-01
2016-09-01
Completed
2,025
Second Line Chemotherapy for S-1 Refractory Advanced Gastric Cancer
2008-03-01
2011-06-01
Completed
300
XIENCE PRIME SV Everolimus Eluting Coronary Stent Japan Post Marketing Surveillance (XIENCE PRIME SV Japan PMS)
2013-05-13
2019-09-01
Completed
312
XIENCE Xpedition Everolimus-Eluting Coronary Stent Japan Post Marketing Surveillance (XIENCE Xpedition SV Japan PMS)
2014-07-01
2020-09-01
Completed
100
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Showa University Fujigaoka Hospital" #1 sponsor was "Bayer" with 3 trials, followed by "Boehringer Ingelheim" with 3 trials
sponsored, "Abbott Medical Devices" with 2 trials sponsored, "Japan Clinical Cancer Research Organization" with 2 trials sponsored and "Japan Rhabdomyosarcoma Study Group"
with 2 trials sponsored. Other sponsors include 1 different institutions and
companies that sponsored additional 11 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Showa University Fujigaoka Hospital"
#1 collaborator was "Boehringer Ingelheim" with 1 trials as a collaborator, "Eli Lilly and Company" with 1 trials as a collaborator, "Korean Cancer Study Group" with 1 trials as a collaborator, "Taiho Pharmaceutical Co., Ltd." with 1 trials as a collaborator and "Tokyo Medical and Dental University" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were
collaborators in the rest 5 trials.
Clinical Trials Conditions at Showa University Fujigaoka Hospital
According to Clinical.Site data, the most researched conditions in "Showa University Fujigaoka Hospital" are
"Coronary Artery Disease" (4 trials), "Anemia" (3 trials), "Renal Insufficiency, Chronic" (3 trials), "Angina Pectoris" (2 trials) and "Gastric Cancer" (2 trials). Many other conditions were trialed in "Showa University Fujigaoka Hospital" in a lesser frequency.
Clinical Trials Intervention Types at Showa University Fujigaoka Hospital
Most popular intervention types in "Showa University Fujigaoka Hospital" are "Drug" (11 trials), "Device" (4 trials), "Biological" (2 trials), "Other" (1 trials) and "Radiation" (1 trials). Other intervention types were less common.
The name of intervention was led by "Molidustat (BAY85-3934)" (3 trials), "Darbepoetin alfa" (2 trials), "cyclophosphamide" (2 trials), "dactinomycin" (2 trials) and "vincristine sulfate" (2 trials). Other intervention names were less common.
Clinical Trials Genders at Showa University Fujigaoka Hospital
The vast majority of trials in "Showa University Fujigaoka Hospital" are
18 trials for "All" genders.
Clinical Trials Status at Showa University Fujigaoka Hospital
Currently, there are NaN active trials in "Showa University Fujigaoka Hospital".
undefined are not yet recruiting,
1 are recruiting,
3 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 12 completed trials in Showa University Fujigaoka Hospital,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Showa University Fujigaoka Hospital, 0 "Phase 1"
clinical trials were conducted, 3 "Phase 2" clinical
trials and 8 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 3 trials that are defined as “Not Applicable".